Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas.
Tabouret E, Furtner J, Graillon T, Silvani A, Le Rhun E, Soffietti R, Lombardi G, Sepúlveda-Sánchez JM, Brandal P, Bendszus M, Golfinopoulos V, Gorlia T, Weller M, Sahm F, Wick W, Preusser M. Tabouret E, et al. Among authors: golfinopoulos v. Neuro Oncol. 2024 Jul 5;26(7):1302-1309. doi: 10.1093/neuonc/noae037. Neuro Oncol. 2024. PMID: 38452246 Free PMC article. Clinical Trial.
Memory in low-grade glioma patients treated with radiotherapy or temozolomide: a correlative analysis of EORTC study 22033-26033.
Klein M, Drijver AJ, van den Bent MJ, Bromberg JC, Hoang-Xuan K, Taphoorn MJB, Reijneveld JC, Ben Hassel M, Vauleon E, Eekers DBP, Tzuk-Shina T, Lucas A, Freixa SV, Golfinopoulos V, Gorlia T, Hottinger AF, Stupp R, Baumert BG. Klein M, et al. Among authors: golfinopoulos v. Neuro Oncol. 2021 May 5;23(5):803-811. doi: 10.1093/neuonc/noaa252. Neuro Oncol. 2021. PMID: 33130890 Free PMC article.
Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma.
Ghisai SA, van Hijfte L, Vallentgoed WR, Tesileanu CMS, de Heer I, Kros JM, Sanson M, Gorlia T, Wick W, Vogelbaum MA, Brandes AA, Franceschi E, Clement PM, Nowak AK, Golfinopoulos V, van den Bent MJ, French PJ, Hoogstrate Y. Ghisai SA, et al. Among authors: golfinopoulos v. Acta Neuropathol. 2024 Oct 9;148(1):50. doi: 10.1007/s00401-024-02811-0. Acta Neuropathol. 2024. PMID: 39382765 Free PMC article.
Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform.
Morfouace M, Novello S, Stevovic A, Dooms C, Janžič U, Berghmans T, Dziadziuszko R, Gorlia T, Felip E, Paz-Ares L, Mazieres J, O'Brien M, Bironzo P, Vansteenkiste J, Lacroix L, Dingemans AC, Golfinopoulos V, Besse B. Morfouace M, et al. Among authors: golfinopoulos v. Sci Rep. 2022 May 18;12(1):8342. doi: 10.1038/s41598-022-12056-0. Sci Rep. 2022. PMID: 35585228 Free PMC article.
Molecular analysis of adolescent and young adult high grade gliomas in the SPECTA-AYA study: Poorly characterised tumours with frequent germline alterations.
Morfouace M, Bielle F, Razis E, Estrade F, Rubio A, Bautista F, de Rojas T, Vieito M, Meade S, Sanson M, Marques AC, Preusser M, Hatcher H, Balasubramanian GP, Pineda E, D'Hondt L, Duerinck J, Michotte A, Mawrin C, Ribalta T, Marucci G, Golfinopoulos V, Pfister SM, Jones DT, McCabe MG. Morfouace M, et al. Among authors: golfinopoulos v. Eur J Cancer. 2025 Jun 18;223:115493. doi: 10.1016/j.ejca.2025.115493. Epub 2025 May 13. Eur J Cancer. 2025. PMID: 40393126 Free article.
Prognostic factors for overall survival in elderly patients with glioblastoma: Analysis of the pooled NOA-08 and Nordic trials with the CCTG-EORTC (CE.6) trial.
Malmström A, Oppong FB, O Callaghan CJ, Wick W, Laperriere N, Gorlia T, Weller M, Henriksson R, Mason W, Platten M, Cantagallo E, Grønberg BH, Reifenberger G, Marosi C, Perry JR; NCBTSG, NOA, CCTG and EORTC Brain Tumor Group. Malmström A, et al. Neurooncol Adv. 2024 Dec 4;6(1):vdae211. doi: 10.1093/noajnl/vdae211. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 39759261 Free PMC article.
Epigenetic landscape reorganization and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma.
Ghisai SA, van Hijfte L, Vallentgoed WR, Tesileanu CMS, de Heer I, Kros JM, Sanson M, Gorlia T, Wick W, Vogelbaum MA, Brandes AA, Franceschi E, Clement PM, Nowak AK, Golfinopoulos V, van den Bent MJ, French PJ, Hoogstrate Y. Ghisai SA, et al. Among authors: golfinopoulos v. bioRxiv [Preprint]. 2024 Mar 20:2024.03.19.585212. doi: 10.1101/2024.03.19.585212. bioRxiv. 2024. Update in: Acta Neuropathol. 2024 Oct 9;148(1):50. doi: 10.1007/s00401-024-02811-0. PMID: 38562747 Free PMC article. Updated. Preprint.
Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091).
Reijneveld JC, Machingura A, Coens C, Taphoorn MJB, Taal W, Clement PM, Idbaih A, de Vos FYF, Klein M, Wick W, Mulholland PJ, Lewis J, Golfinopoulos V, Ghislain I, Bottomley A, van den Bent MJ; EORTC Brain Tumor Group. Reijneveld JC, et al. Among authors: golfinopoulos v. Eur J Cancer. 2023 Sep;190:112946. doi: 10.1016/j.ejca.2023.112946. Epub 2023 Jun 19. Eur J Cancer. 2023. PMID: 37453240 Free article. Clinical Trial.
72 results